Podcasts about Endocrinology

Send us a textJosh Wageman is a returning guest on our show! Be sure to check out his first appearance on episode on 869 of BBR!Josh Wageman is a Clinical Lipid Specialist with multiple doctoral degrees who formerly practiced in Endocrinology. His PhD work focused on cholesterol disturbances in Alzheimer's Disease and, although he also has a Doctorate in Physical Therapy, he is best known for his role in teaching lipid physiology.He serves as an adjunct professor at several medical programs and his goal is to help you, whoever you are, NOT have heart attacks, strokes, and dementia by explaining complicated biochemical concepts in a relatable way!Employing a smorgasbord of metaphors, pictures, and catchphrases, his latest book The Home Security System and the Lipid Neighborhood serves as a valuable reference for clinicians and non-clinicians alike, bringing refreshing relatability to complex biochemical topics. Through a lipid-lens, you'll learn, laugh, and love your way through its pages…and in the end, you'll undoubtedly add “life to your years!”Josh is active in Youth Ministries at Heritage Bible Church in Boise, Idaho, and resides there with his family. He also enjoys Crossfit, basketball, Ultimate Frisbee, and all sports that don't involve skates.Find Dr. Wageman at-Amazon- The Home Security System and the Lipid Neighborhood IG- @wagemanjoshLK- @Josh WagemanFind Boundless Body at- myboundlessbody.com Book a session with us here!

In this episode, we take a closer look at tirzepatide, a type 2 diabetes medication also used to help with weight loss. Postmenopause weight gain can be a normal part of aging, and there are some questions about whether medications like tirzepatide could be useful and safe for postmenopausal women. Host Aaron Lohr talks with Maria Daniela Hurtado Andrade, MD, PhD, assistant professor of medicine at Mayo Clinic Florida, and Regina Castaneda, MD, a research fellow at Mayo Clinic College of Medicine & Science. They presented an abstract at ENDO 2025 titled, “One-Year Real-World Weight Loss Outcomes with Tirzepatide in Postmenopausal Women With and Without Hormone Therapy.” Show notes are available at https://www.endocrine.org/podcast/enp105 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Book a FREE functional health discovery call HERE. Many women in midlife are silently battling anxiety, fatigue, and mood swings while doing all the “right” things—working hard, leading, caring for everyone else. But few realize how closely mental health and nutrition are connected.  In this episode, Tanya opens up about her decades-long struggle with anxiety and disordered eating and how undernourishment disrupted her body's ability to make key neurotransmitters. She unpacks how protein and amino acids become the building blocks for mood, energy, and hormones—and why digestion, gut health, and liver function all play a vital role in restoring balance.   Key Topics Covered: Tanya's personal journey with anxiety and bulimia How amino acids become neurotransmitters and hormones The gut-brain-liver connection in mood regulation Protein needs for women in midlife Nutrients essential for neurotransmitter synthesis  How stress and cortisol disrupt serotonin production Faith-based mindset: nourishment as stewardship Resources & References: Frontiers in Endocrinology, 2019 – The Tryptophan Pathway and Serotonin PubMed: Dietary Protein and Brain Serotonin Synthesis ResearchGate: Gut-Brain Axis and Mood Regulation Cleveland Clinic: Understanding Serotonin   I hope this episode blesses you! Xoxo, Tanya Episode Resources: Episode Catalog   My trusted Supplement Dispensary: Aligned Vitality Fullscript Dispensary My trusted Telehealth Peptide Provider:  EllieMD_Tanya Engesether *I do get a small commission when you use one of the above affiliate links. 3 Ways To Connect With Me: 1️⃣COACHING: Are you READY to Lead Well, Live Well and BE Well? Book a FREE discovery call with me to find out more about functional health coaching. It's the accountability and guidance you need to reclaim your health and happiness! ➡︎ https://gracefilledleader.com/coaching   2️⃣ FACEBOOK: Become part of our Supportive Facebook Group. Connect, share, and learn with others navigating life and leadership ➡︎ https://gracefilledleader.com/community   3️⃣ CONTACT: Leave me a question or comment ➡︎ https://gracefilledleader.com/contact   "Yes! Finally, a podcast helping others become the thriving leaders they're meant to be outside of hustle-culture! This is an amazing resource! Thank you so much for sharing and helping us become Spirit-driven, peaceful leaders!"    If you can relate, please consider rating and reviewing my show! It helps me reach more people – just like you – to help them change their future. Don't forget to follow the show so you don't miss any episodes! And, if you're feeling really generous, I'd be SO honored if you would share this podcast with someone.   Click here to view our privacy policy.   Reminder:  The information you hear on this show is not meant to diagnose, treat, cure or prevent disease.  It is for educational purposes only. Always consult with your own health practitioner before you make any changes to your health.

“It's kind of a miracle, frankly,” says Dr. John Buse, a distinguished professor at the University of North Carolina School of Medicine, referring to the effectiveness of GLP-1 receptor agonist medications such as Ozempic in treating type 2 diabetes, promoting significant weight loss, and reducing cardiovascular risk. As a physician scientist for the last three decades at UNC, Dr. Buse has played a key role in ushering in this new era of diabetes care, leading or participating in over 200 clinical studies on this class of drugs and others. “Nothing has impacted diabetes care like the GLP-1 receptor agonists. I have lots of patients whose diabetes was never well controlled who have seen all their metabolic problems essentially resolved.”  In this fascinating conversation with Raise the Line host Lindsey Smith, Dr. Buse not only explains how these drugs work, but also provides a clear-eyed look at side effects, and addresses issues of cost and access. Join us for the remarkable story – including the role played by Gila monsters -- behind one of the biggest developments in medicine over the past several years from a world renowned diabetes researcher and clinician. Mentioned in this episode:UNC School of Medicine If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Dr. Silvana Obici, Chief of the Division of Endocrinology at Stony Brook Medicine and Medical Director of the Stony Brook University Hospital Diabetes Center, joins Heart of The East End Gianna Volpe on WLIW-FM to discuss lifestyle choices ahead of Diabetes Awareness Month.Listen to the playlist on Apple Music

Guest: Sujith Cherian MD, FCCP, DAABIP Obesity impacts how the lungs function in a variety of ways, and understanding these impacts is essential for interpreting pulmonary function tests, identifying restrictive or obstructive patterns, and managing ventilation. Learn more with Dr. Sujith Cherian, who's an Associate Professor in the Divisions of Critical Care, Pulmonary, and Sleep Medicine at University of Texas Health-McGovern Medical School and the Director of Interventional Pulmonology and Pleural Diseases at Lyndon B. Johnson Hospital in Houston. He also spoke about this topic at the 2025 CHEST Annual Meeting.

Long-time Alfacast friend, Dr. Edith​ Ubuntu Chan, joins this episode to discuss her most recent trip to Thailand for a 9 day Dark Room retreat and how this experience has aided her current practice of Blindfold Perception Training.  Now working with adults, she sees this as a powerful tool for transitioning back to our innate Telepathic nature. Edith has devoted her life to exploring the frontiers of Human potential, while sharing her passion as a holistic medicine doctor to help fellow Visionaries awaken to greater possibilities.   Dr. Edith is a doctor of Chinese Medicine and Acupuncture and author of the Amazon #1 bestselling book SuperWellness. Dr. Edith's academic background includes a Doctoral Fellowship at Five Branches University (specializing in Endocrinology and Neuromuscular Medicine), a four-year graduate degree from American College of Traditional Chinese Medicine, and a bachelors in Applied Mathematics with magna cum laude from Harvard University. Show links: https://www.dredithubuntu.com/ Learn The True Nature Of Dis-Ease & How Our Bodies Actually Work: https://alfavedic.com/themyth/ Join Our Private Community And Join In The Discussion: https://alfavedic.com/join-us/ Looking for a career in the healing arts?  Get accredited in Acute Integrative Homeopathy™ https://alfavedic.com/practicioner Start healing yourself and loved ones with ozone! https://alfavedic.com/ozone Protect yourself & your teens from media manipulation & groupthink w/ Dani Katz's Pop Propaganda Course! http://alfavedic.com/poppropaganda Get our favorite blue blocker glasses! Use code 'alfavedic' for 10% off! https://alfavedic.com/raoptics Join Qortal for free, the truly decentralized internet. https://qortal.dev/downloads Learn how to express your law and uphold your rights as one of mankind. https://alfavedic.com/lawformankind Alfa Vedic is an off-grid agriculture & health co-op focused on developing products, media & educational platforms for the betterment of our world. By using advanced scientific methods, cutting-edge technologies and tools derived from the knowledge of the world's greatest minds, the AV community aims to be a model for the future we all want to see. Our comprehensive line of health products and nutrition is available on our website. Most products are hand mixed and formulated right on our off grid farm including our Immortality Teas which we grow on site. Find them all at https://alfavedic.com​​​​​​​​​​​​​​ Follow Alfa Vedic: https://linktr.ee/alfavedic Follow Mike Winner: https://linktr.ee/djmikewinner

With a calcium score of zero, is there any fat in your diet?  Are there any recommended supplements for IBS?What is the safest and most appropriate dose of vitamin D3 for most seniors?

INFINITY Study on the timing of thyroid medication ingestionI have a growth near my eye that is changing in color and becoming crusty. What should I do?I've been suffering from hip pain for the last three years. Any suggestions on what to do?Could toxic exposures like mold cause conditions like low thyroid or autoimmunity?

Guest: Jaime Moore, MD Discussing weight with pediatric patients and families is a nuanced challenge shaped by stigma, culture, and access—but it's also a vital opportunity for early intervention. Dr. Jaime Moore shares how to build confidence, counter bias, and leverage practical tools and partnerships that support long-term, personalized care. Dr. Moore is an Assistant Professor of Pediatric Nutrition at the University of Colorado Anschutz School of Medicine and part of the Children's Hospital Colorado Lifestyle Medicine Program. She also spoke about this topic at the 2025 American Academy of Pediatrics (AAP) National Conference and Exhibition.

Join Dr. Cecilia Lansang, Associate Editor of Endocrine Practice, Professor of Medicine, and Director of Endocrinology at Cleveland Clinic, as she speaks with Dr. Kristen Flint, Interim Director of Quality and Safety for Endocrinology at Massachusetts General Hospital, Attending Endocrinologist at MGH, and Instructor at Harvard Medical School, about her team's quality improvement project, “Expanding Access to Continuous Glucose Monitoring in Medicare Patients Receiving Specialty Diabetes Care.” This episode covers:Strategies for implementing quality improvement interventions in a large academic diabetes specialty clinicKey interventions that increased CGM utilization, including targeted provider education, workflow optimization, and patient outreachLessons for advancing equitable implementation and sustaining quality improvement over time Tune in for practical insights on bridging policy changes and clinical practice to improve CGM access for Medicare patients. Read the full article in the August 2025 issue of Endocrine Practice here.

In this powerful 400th episode (Whoop), I'm joined by Dr. Jerilynn Prior, a world-renowned expert in women's hormones and reproductive health. Together, we unpack what really happens during perimenopause and why understanding progesterone can be life-changing for women navigating this transition. We discuss: ✨ What perimenopause actually is and how it differs from menopause ✨ The common symptoms/issues women experience during perimenopause's hormonal chaos ✨ Why estrogen levels are often highest (not lowest!) during this phase ✨ The vital role of progesterone and why it should be the go-to treatment for relief ✨ How progesterone therapy supports sleep, mood, heart health and more ✨ The link between progesterone and hot flashes, night sweats, and heart attack risk ✨ Why birth control pills and estrogen therapy can sometimes make perimenopause symptoms worse ✨ And much more empowering, evidence-based hormone care! If you've ever wondered why perimenopause feels so unpredictable or how to support your hormones naturally - this conversation will bring clarity and hope.

See all the Healthcasts at https://www.biobalancehealth.com/healthcast-blog You will learn: What holds up new treatments for diseases and conditions How long the FDA sits on a known safe medical medication before it is released to the public. Why safe and effective drugs are NOT approved by the FDA Why doctors are forced to use medications off label How you can help During my 44 years of medical practice, I have encountered conditions for which there is no approved medication or surgical treatment available as recognized by the American College of OBGYN or the FDA. This situation can present challenges both for physicians managing these patients and for individuals seeking relief from their symptoms. This issue is not often addressed on Dr Oz, in the news, or at medical conferences. For many conditions, physicians wait for the development of approved medications or treatments, and in the meantime may inform patients that there is currently no treatment or cure available. Some doctors may attribute a patient's concerns to aging, stating that it is a universal experience. While this may be accurate, such explanations may not provide comfort to patients seeking solutions to their symptoms. This lack of helpful guidance can discourage individuals from seeking medical care when they feel their concerns are not acknowledged. This seems to result from insurance companies prioritizing cost savings by minimizing patient care.  Every year insurance companies decrease what they pay doctors for their services, while their expenses go up, and the Government requires more and more work behind the scenes like HIPPA, OSHA, and Clia requirements that costs more to deliver the same service.  If you have a problem with the time your doctor spends with you then blame the insurance companies whose profits rise every year…Soon doctors will do what I do and only take cash.  The practice of medicine is not working in a free market. While insurance limits the prescriptions of medication to those meds that are FDA Approved, the FDA and medical specialty colleges often delay approval of new, low-risk treatments for up to 20 years after their effectiveness is demonstrated. This lengthy process should be reconsidered to treat people who are ill and suffering, now. There is plenty of research in the medical journals that explain the safety of new and effective treatments that can save peoples' lives that are not FDA approved yet. The FDA is not interested in expediting the release of medication/ devices quickly to those people who need help now. They drag out the testing of a medicine that has been effective for years and may or may not approve it. On the flip side they have approved many drugs that later are found to have severe side effects, and they just change the warnings on the medication inserts. They don't take them off the market except in severe cases. Drugs that have worked treating patients successfully are being used but are not FDA approved. These “grandfathered drugs” don't need to go through the testing that new drugs go through because they work with few well-known risks. I use many if these medications because they are inexpensive for my patients and are often more effective than new meds for the same problem. One of the drugs that the FDA has not had to approve is Armour Thyroid, a natural thyroid replacement. My experience with treatments not approved by the FDA Armour Thyroid: Armour Thyroid (AT) has been prescribed by doctors to replace thyroid hormones for about 100 years. It is natural, made from Pig thyroid. It only comes from “medical Pigs” that are raised for medical purposes.  We use medical pigs for skin grafts, and other parts of the pig to treat human diseases like heart valve replacements.  Armour Thyroid is composed of the four thyroid hormones that humans make: T4, T3, T2, T1. The synthetic thyroid replacement, Synthroid/levothyroxine is only T4.  The active form of thyroid is T3, and it requires an enzyme to convert T4 into T3. If a person can't convert T4 into active T3 then nothing improves except the blood levels of T4, and TSH. The majority of women cannot convert T4 into T3. Therefore, if they take Synthroid or levothyroxine and their doctor only checks their TSH level and not the level of free T3 and free T4 to see if the Thyroid is working, then women are told that they are healed, yet they know they are not because none of their low thyroid symptoms are resolved. When this happens, doctors tell female patients that it is all in their heads and dismiss us when we tell them we are not cured with this synthetic T4 medication. Yet Synthroid is a chemical, and AT is natural from medical pigs, so the FDA is trying to Bann the only drug that has successfully treated millions of women. PS. Synthroid was not tested on women like many other drugs that were passed through the FDA before 2014! If you think this is a small problem, think again. Thyroid hormones are vital to human life, and the thyroid gland requires Iodine in the diet. The Midwest US has no Iodine in the soil or water. Therefore, this area is overburdened with hypothyroidism. I have been on AT for 50 years without complication and I have prescribed it thousands of times ever since I went into private practice.  AT works to relieve the symptoms of hypothyroidism for women and men, and it works better for women that the “new” drug Synthroid/levothyroxine, which is FDA approved. You ask how could the FDA approve a drug that doesn't successfully treat women? It is because Synthroid was not tested on women!  Until 2014 the FDA did not test women in the required drug trials.  AT works for us (women), Levothyroxine does not. Now the FDA wants to ban AT. It is not approved because it was around for decades before they started testing medications like they do now, and the history of successful treatment should stand on its own merit! Example 2: Bio-Identical Hormones BIH:  BIHs had not been approved by the FDA until recently and there was no announcement that they are now approved for women who have hormone deficiency symptoms or postmenopausal symptoms. Most doctors and women who have been afraid of the only hormones that can help them, bioidentical hormones, haven't yet been told that NOW, FINALLY the medical colleges and the FDA finally have quietly approved BI hormones.  There are no pure estradiol and pure testosterone pellets that are made by a drug company for women. My patients get their estradiol and testosterone pellets from a compounding pharmacy.  I have been prescribing BIH since 1985 without FDA approval because the oral estrogen formulations that were available at pharmacies caused weight gain and put women at high risk for blood clots. Non-oral BI hormones have fewer risks than FDA approved estrogens.  I waited more than 45 years for the FDA to approve BI hormones for treatment of women.  All those women in the last 45 years who were taking FDA approved estradiol and those who couldn't tolerate them have been harmed by FDA goals of never approving compounded or bio-identical hormones.  The delay has harmed 50% of American women. Example #3 Devices for Weight Loss I was involved in the discovery and testing of a unique device that stimulated acupuncture points with a TENS-unit-type patch connected to your cell phone for easy adjustment of your hunger or “fullness”. The FDA requires testing to approve any new device so the group of investors I was part of had to invest thousands of dollars for a device we already knew worked. The FDA told the investigators of all new devices who they should test, who they can't have in the study, and how long the testing should take. I found their parameters for the study of this device to be unrealistic. The women in our test group could not be taking hormones of any kind (birth control, ERT, HRT), and could not be on antidepressants, could not have diabetes or insulin resistance or be on any drug that assisted in weight loss. These women subjects had to be a certain BMI (level of obesity) and had to be tested repeatedly with weight and body composition measurements None of my patients who needed weight loss could participate.  Most GYN patients are on some medication or supplement, so the FDA made this study of our device so narrow that REAL WOMEN weren't tested! Sadly, we lost many women in the control group from the study because they were NOT losing weight while the ones on the device were obviously dropping pounds, so we had trouble maintaining test subjects. The testing phase of this simple device took 7 years! Our device works and no one will ever know about it or be able to use this non-medicinal weight loss device because when the FDA rejects your device you will be breaking the law if you produce and sell it directly to the public. It has no side effects or dangers..it just controls the amount you eat with stimulation of an acupuncture point. There are many ways to change this situation, and it takes years and billions of dollars to change the whole system of bringing treatments to patients quickly.  I'm afraid I won't see a revolution of the way we bring medicines and devices to market during my lifetime. Currently there is a 17-year delay between proving a drug or device works for a particular illness or condition and when it becomes available to doctors and patients. So what do we do in the meantime?  I seek treatments for patients who are unresponsive to traditional medicine by reading journals like Life Extension, that inform doctors and patients alike about new effective solutions for common medical complaints and diseases that the FDA has ignored or stymied with endless drug trials.  Life Extension Magazine highlights studies on new medications for diseases without an FDA approved solution and publicizes diagnostic tests often overlooked by mainstream publications because they are not yet FDA approved. The medical journals I read (New England Journal of Medicine, JAMA, Menopause, Metabolism and Endocrinology, Journal of Age management, to name a few) offer treatments for orphan diseases or even common problems that haven't been blessed by the FDA. It takes an average of 17 years from the culmination of research on a new drug, test or device until it is approved for use by the public! At the end of this Blog, I will give you a link to make your voice heard by signing a petition to shorten the approval of new treatments and medications from the average of 17 years to 3 years! My patients don't have time to wait for relief, and that may be the case for you as well. If you want to do something to help, please click this link and let the FDA know how you feel. Please sign a Petition to enact an amendment to the FOOD, DRUG and COSMETIC ACT, by going to: https://age-reversal.net/fda/

In the United States, the Food and Drug Administration doesn’t regulate supplements for safety and efficacy, so manufacturers don’t have to disclose their ingredients. We can’t always know for certain what’s in supplements we buy over the counter. Host Aaron Lohr talks with Meghana Pattipati, MD, an endocrine specialist at Ochsner Lafayette General Medical Center in Louisiana. Dr. Pattipati presented a study at ENDO 2025 in San Francisco titled, “Beware of the Hidden Ingredients and Supplement Use in Your Patients With Elevated Testosterone.” The presentation describes a case where a patient unknowingly ingested an ingredient that had a significant endocrine impact. Show notes are available at https://www.endocrine.org/podcast/enp104 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

If you're a healthcare provider, patient, or just interested in the role of empathy and self-awareness in medicine, you won't want to miss this episode.I'm thrilled to be joined once again by Dr. Mickey Liebowitz—an accomplished endocrinologist, author, and a true champion for bringing emotional intelligence into the world of healthcare.Dr. Liebowitz and I talk about the current state of the U.S. healthcare system—not just looking at the advancements in medicine and technology, but focusing on something that's often overlooked: the human connection between doctors and patients. Together, we discuss how easy it is for that critical relationship to become transactional with the ongoing pressures of the business side of medicine, and why that matters for both patients and practitioners.Dr. Liebowitz shares some powerful stories from his decades of experience that really drive home just how important emotional intelligence is in creating trust, hope, and better outcomes. We also discuss his brand new book, "The EQ Prescription," and his concept of the Emotional Intelligence Zone—a tool that can help both professionals and patients foster real, meaningful connections in healthcare.We share real-life scenarios, practical advice, and the reasons why optimism and the willingness to change can make such a difference in our health journeys.Mickey Lebowitz, originally from Brooklyn, New York, is a graduate of SUNY-Oswego (magna cum laude and student athlete of the year) and Upstate Medical University and a board-certified endocrinologist/diabetologist (Fellow, American College of Endocrinology). He has worked in a physician-owned practice, as an employed physician in the VA system, and currently as an endocrine hospitalist.He spent seven years as a hospital-based senior medical quality director and is currently a chief medical officer at a healthcare transportation company. He's an educator, serving as the medical director of a physician assistant program in upstate New York, and an author whose first book, Losing My Patience, was published in 2009. Through Six Seconds, he is a certified assessor, practitioner, facilitator, and coach in emotional intelligence (EQ), coaching clinicians, nurses, and healthcare students on leadership, professionalism, and interpersonal relationships. He has given countless presentations and workshops on EQ locally and nationally, and is in the process of publishing his research on the impact of EQ on his PA program's students.He has been on the list of Best Doctors in America, is an honoree of the Juvenile Diabetes Research Foundation (Breakthrough TID), and has received awards for preceptor and resident teaching, community service for educating health-care professionals on wellness and burnout, dedication and loyalty to the medical profession, and excellence in health-care education, as well as the NYSSPA Physician Advocate of the Year award.Spirit of EQ In each episode, Jeff and Eric will talk about what emotional intelligence, or understanding your emotions, can do for you in your daily and work life. For more information, contact Eric or Jeff at info@spiritofeq.com, or go to their website, Spirit of EQ.You can follow The Spirit of EQ Podcast on Apple Podcasts, Android, or on your favorite podcast player.New episodes are available on the 2nd and 4th Wednesdays every month!

On today's episode we discuss the latest hot topic in the fitness industry - weight loss drug, Retatrutide. What are the benefits? Are there potential side effects? What does this mean for bikini competitors in prep, dieting hard for a show? Follow us on IG @preplifepodcast @glamgirlbikini @amyehinger @leemarie183 Watch on YouTube: Glam Girl Bikini   Join the team: https://www.glamgirlbi...   1st Phorm Supplements we use: https://1stphorm.com/?... Key references • Jastreboff AM, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity. N Engl J Med / related publications (phase-2 reports). • Sanyal AJ, et al. Retatrutide and liver fat/liver outcomes. Nature Medicine 2024. • Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP). N Engl J Med 2021. • Jastreboff AM, et al. Tirzepatide once weekly for obesity (SURMOUNT) and related reports. PubMed/NEJM/SURMOUNT analyses. • Conceição-Furber E, et al. Is glucagon receptor activation the thermogenic solution? Frontiers in Endocrinology, review of GCGR and energy expenditure mechanisms. • Frampton J, et al. The acute effect of glucagon on components of energy expenditure. Int J Obes / Nature Metabolism meta-

Send us a textDr. Vanessa Rodriguez is a Board-Certified Adult Endocrinologist with 20+ years of experience in the areas of Diabetes, Metabolism, and other endocrine conditions with a Direct Specialty Care practice in Delray Beach, Florida.She shares insights on planning for Direct Specialty Care after starting an insurance practicesaving overhead expenses with co-working spacesthe benefits patients enjoy through her membership program, even though they have insuranceand more!Books mentionedSparks Start Fires by Dr. Julie GuntherThe Official Guide To Starting Your Own Direct Primary Care Practice by Dr. Douglass FarragoCo-op Space in Floridahttps://khospace.com/locations/delray-beach-fl/Find Dr. Vanessa Rodriguez at info@endocrinologywellness.com and visit her at https://endocrinologywellness.com  Support the showMASTERING PRIVATE PRACTICE CONFERENCE by Doctors On Social Media. #SoMeDocsPP Live Sept 25-27, 2025. Recording available. Use my affiliate link to attend, here --> Record your question easily here --> FREE Direct Care Guide to get you started --> Join the Direct Care Society private Facebook group here. Monthly coaching sessions & a community that gets you. --> Own a DSC practice and want to share your story? Apply here EMR I'm currently using in my Direct Care practice Simple Practice HIPAA Compliant Email with Paubox Get $250 Credit Here Find me on LinkedIn https://linkedin.com/in/teadpm More resources teadpm.com

Send us a textDr. Vanessa Rodriguez is a Board-Certified Adult Endocrinologist with 20+ years of experience in the areas of Diabetes, Metabolism, and other endocrine conditions with a Direct Specialty Care practice in Delray Beach, Florida.She shares insights on planning for Direct Specialty Care after starting an insurance practicesaving overhead expenses with co-working spacesthe benefits patients enjoy through her membership program, even though they have insuranceand more!Books mentionedSparks Start Fires by Dr. Julie GuntherThe Official Guide To Starting Your Own Direct Primary Care Practice by Dr. Douglass FarragoCo-op Space in Floridahttps://khospace.com/locations/delray-beach-fl/Find Dr. Vanessa Rodriguez at info@endocrinologywellness.com and visit her at https://endocrinologywellness.com  Support the showMASTERING PRIVATE PRACTICE CONFERENCE by Doctors On Social Media. #SoMeDocsPP Live Sept 25-27, 2025. Recording available. Use my affiliate link to attend, here --> Record your question easily here --> FREE Direct Care Guide to get you started --> Join the Direct Care Society private Facebook group here. Monthly coaching sessions & a community that gets you. --> Own a DSC practice and want to share your story? Apply here EMR I'm currently using in my Direct Care practice Simple Practice HIPAA Compliant Email with Paubox Get $250 Credit Here Find me on LinkedIn https://linkedin.com/in/teadpm More resources teadpm.com

ABOUT THIS EPISODEEvery provider on a multidisciplinary neuroendocrine cancer (NET) team brings a distinct and valuable perspective. In this episode, UCLA endocrinologist Dr. Run Yu sheds light on the unique role of the endocrinologist. He explains what endocrinology is, which types of NETs may require an endocrinologist's care, and how endocrine issues intersect with NET management. Dr. Yu also explores the “endocrine” side of neuroendocrine—discussing key concerns related to diabetes, thyroid, parathyroid, and adrenals.TOP TEN QUESTIONS 1. What is an endocrinologist? What training is involved? 2. Since there is “endocrine” in neuroendocrine, would NET patients need to see an endocrinologist? When should one see an endocrinologist? What is your role with your medical team? How is an endocrinologist different from a medical oncologist?If someone with neuroendocrine cancer needs to see an endocrinologist, does that person need to specialize in neuroendocrine cancer?3. If someone sees both an endocrinologist and a medical oncologist, what do you do and what does the medical oncologist do? How are treatment decisions made or coordinated? (Who is the “quarterback?”)4. Who orders the somatostatin injections? Are they done through the oncologist or endocrinologist? What if I need something else to control my neuroendocrine cancer symptoms?5. What are hormonal issues? How do I know if my neuroendocrine tumor produces hormones? 6.  What hormone tests do you check? 7. What tumor markers do you check? How do you interpret them?8. When might endocrine issues arise with neuroendocrine cancer?ThyroidParathyroidAdrenal9. How do hyperglycemia and diabetes issues relate to neuroendocrine cancer?What is hyperglycemia, pre-diabetes and diabetes?Is diabetes inevitable with NET? Is diabetes inevitable with somatostatin analogue therapy?Does metformin potentially slow down NET tumor growth?What monitoring do you recommend?10. When does one encounter hypoglycemia with neuroendocrine cancer?What is insulinoma? What is the treatment?BONUS: What is on the horizon for neuroendocrine cancer that you're most optimistic about? ABOUT DR. RUN YURun Yu, MD, PhD, received his MD degree from Peking Union Medical College in Beijing and his PhD degree in pharmacology from the University of Rochester in New York. Dr. Yu completed an endocrine research fellowship, an internal medicine residency, and a clinical endocrinology fellowship at Cedars-Sinai Medical Center.Dr. Yu's clinical and research interests include diabetes, thyroid, and endocrine tumors and syndromes.Dr. Yu enjoys describing novel clinical findings in endocrinology.For more information, visit https://www.ncf.net/podcast/47For more information, visit NCF.net.

Recently the Endocrine Society held its 12th annual Type 1 Diabetes Fellows Series program, which combines comprehensive education on type 1 diabetes with career development opportunities to build knowledge, practical skills, and a lasting network of colleagues. For this episode, host Aaron Lohr talks with Desmond Schatz, MD, medical director of the Diabetes Institute and director of the Clinical Research Center at the University of Florida. Dr. Schatz gave a talk at the fellows series program titled, “Immunotherapies for Type 1 Diabetes: Need for Early Detection and Screening.” This year’s fellows series program and this episode were made possible by the support of Abbott Diabetes Care, CeQur Corp., Dexcom Inc., Insulet Corp., Breakthrough T1D (formerly the Juvenile Diabetes Research Foundation), Lilly USA, Mankind Pharma Limited, Medtronic Inc., Novo Nordisk Inc., and Vertex Pharmaceuticals Inc. Show notes are available at https://www.endocrine.org/podcast/enp103 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Join leading experts Fariha Abbasi-Feinberg, MD, FAASM, Medical Director of Sleep Medicine at Millennium Physician Group and President Elect for the American Academy of Sleep Medicine; Inderpreet K. Madahar, MD, MBBS, Assistant Professor of Endocrinology, Diabetes, and Metabolism at Corewell Health; and Sarah Nadeem, MD, FACE, Assistant Professor, Section of Endocrinology, Diabetes, and Metabolism at Baylor College of Medicine, Houston, TX, as they discuss the complex relationship between obstructive and central sleep apnea and metabolic disorders such as obesity and type 2 diabetes.Key topics include:Who should be screened for sleep apnea and the recommended screening toolsFirst-line and adjunctive therapies for managementThe evolving role of multidisciplinary careHow clinical practice is shifting with the recent FDA label expansion of tirzepatide (Zepbound®)When tirzepatide may be considered alongside or in place of CPAP, APAP, and BiPAP therapiesTune in for practical insights to better identify, manage, and support patients at risk. This episode is made possible through a sponsorship from Lilly.

What if diabetes wasn't about sugar at all—but about strength, food, and family?”In this power-packed episode, Ryan Fernando sits down with Dr. Roshani Sanghani, a US-certified endocrinologist, to uncover the truth about diabetes across generations. From children being diagnosed at just 5 years old, to grandparents relying on pills instead of power, we explore how the right choices—nutrition, strength training, and awareness—can rewrite the health story of your entire family.This isn't just a podcast—it's a wake-up call.Are you ready to change the way you see diabetes forever?Full podcast Important links:⁠⁠⁠Ryan Fernando App⁠⁠⁠⁠⁠⁠Diet plan ⁠⁠⁠⁠⁠⁠Blood test ⁠⁠⁠⁠⁠⁠Cancer screening ⁠⁠⁠⁠⁠⁠All tests ⁠⁠⁠Socials:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Link tree⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠Products: ⁠⁠⁠1Chaze marine collagen ⁠⁠⁠⁠⁠⁠Collagen cranberry flavor ⁠⁠⁠⁠⁠⁠1Chaze ⁠⁠⁠⁠⁠⁠Wheatless book ⁠⁠⁠⁠⁠⁠Eating Secrets of Champions⁠⁠Find Roshani here: Instagram YouTube Website LinkedIn Buy her book Time Stamps0:00 – Trailer1:55 – Intro2:25 – What is Endocrinology?4:07 – Is Diabetes a Hormonal Issue?4:58 – Early Signs of Diabetes6:08 – Is Screening Necessary?7:10 – Type 1 vs Type 2 Diabetes8:58 – Is Low Blood Sugar Dangerous?10:48 – Insulin Resistance vs Sensitivity14:07 – Why Insulin Matters16:03 – India's Pre-Diabetes Pandemic17:33 – Can Schools Prevent Diabetes?19:08 – 3 Key Factors in Diabetes25:22 – Test Insulin & Glucose Together?26:03 – Why Insulin Is High in Youth27:25 – Parents' Role in Preventing Diabetes30:30 – Can Stress Cause Diabetes?32:47 – Can Lifestyle Reverse Diabetes?36:18 – Are Carbs Really Bad?39:02 – How to Carb Count Simply44:57 – Are Curd, Idli & Dosa Healthy?49:10 – Food Mistakes Vegetarians Make50:56 – Acid Reflux & Feeling Full54:54 – Managing Sugar Without Counting Calories59:07 – Diabetes Tips for Stressed Individuals1:05:00 – Why Seniors Must Work Out1:07:35 – Why Ryan Trains His Parents1:08:39 – Rapid Fire1:17:30 – Outro

Drs Kaniksha Desai and Julie Ann Sosa discuss the 2025 American Thyroid Association guidelines for the management of differentiated thyroid cancer. This podcast is intended for healthcare professionals only. Kaniksha Desai, MD, Associate Professor of Medicine, Department of Endocrinology, Stanford School of Medicine, Palo Alto, California Julie Ann Sosa, MD, Professor, Department of Medicine, University of California, San Francisco (UCSF) To read a partial transcript or to comment, visit: https://www.medscape.com/index/list_15483_0

Welcome back to Ozempic Weightloss Unlocked, the podcast where we dive into the latest news and analysis about one of the most talked-about treatments for weight loss and metabolic health.Let us jump right in with some breaking research. According to The Lancet Diabetes and Endocrinology, new clinical trial data shows that a triple-dose of Ozempic, meaning 7.2 milligrams weekly, resulted in almost nineteen percent average weight loss in adults without diabetes. That is a substantial jump compared to the sixteen percent with the standard 2.4 milligram dose, and only around four percent with a placebo. Nearly half of those on the higher dose lost at least twenty percent of their body weight, and a third saw weight reductions of twenty-five percent or more. Even among adults with type 2 diabetes, the higher dose achieved thirteen percent weight loss, compared to ten percent with the lower dose. Waistlines, blood pressure, blood sugar, and cholesterol all improved on the higher dose. Safety remained solid, with the most common side effects being manageable nausea and diarrhea that usually settled down over time. Importantly, there was no increase in serious adverse events.Now, for lifestyle impacts and long-term use. A population-wide study presented at the European Association for the Study of Diabetes reports that half of people who start Ozempic for weight loss stop taking it within a year. Cost is a major factor, with the lowest dose costing around two thousand Euros a year in some areas. Younger adults and people from lower income neighborhoods were far more likely to discontinue, likely due to financial barriers. Adverse effects like nausea, and pre-existing conditions, played a role as well. The study found that men were more likely to stop early than women, and adherence was especially hard for those with a history of psychiatric conditions or chronic illness. That is concerning, since people with these conditions often need the benefits the most. Once people stop the medication, weight is often regained, showing just how important it is to find sustainable approaches to weight management.On the topic of who benefits most, a study in Frontiers in Clinical Diabetes and Healthcare highlighted that emotional eating can reduce the effectiveness of Ozempic. The medication is best for people who overeat due to external cues like the smell or appearance of food, rather than for those who eat in response to boredom, anxiety, or sadness. Health experts now recommend that healthcare providers assess a person's relationship with food before prescribing Ozempic or its counterparts. If emotional eating is a primary issue, psychological support may be necessary alongside medication.For those worried about cardiovascular risks, the REACH study presented at the annual meeting of the European Association for the Study of Diabetes confirmed that Ozempic stands out for reducing cardiovascular risk, even among those with multiple chronic conditions. Large-scale, real-world data reinforce its value, particularly in older populations who often have comorbidities like heart disease.Let us also touch on a warning that has emerged: rapid weight loss with medications like Ozempic can cause muscle loss, particularly in women and older adults. While the fat loses fast, it is essential to protect muscle mass with diet and exercise. Experts stress that lifestyle habits—good nutrition, adequate sleep, and physical activity—remain crucial for long-term results, even when taking medication.To sum up, Ozempic continues to make headlines for its effectiveness, but sticking with the medication is a challenge for many due to cost, side effects, and complex eating habits. Emotional and physical health both need to be addressed for the best outcomes. As always, open discussion with healthcare professionals about individual goals, potential barriers, and long-term maintenance is vital.Thank you for tuning in to Ozempic Weightloss Unlocked. Make sure to subscribe so you never miss an episode. This has been a quiet please production, for more check out quiet please dot ai. Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

In this episode, we cover type 1 diabetes and especially insulin delivery systems. Host Aaron Lohr talks with Grazia Aleppo, MD, from Northwestern University’s Feinberg School of Medicine and Diana Isaacs, PharmD, director of education and training in diabetes technology at the Cleveland Clinic. This episode is certified for up to 0.5 AMA PRA Category 1 credits and ABIM MOC points. However, claiming those points requires taking a pre-episode test. Then you must listen to the episode on the Endocrine Society’s Center for Learning website, followed by a post-episode test and evaluation. Please check the show notes for the appropriate link. This episode is supported by educational grants by MannKind Corp. and Insulet Corp. Show notes are available at https://www.endocrine.org/podcast/enp102 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

 Many Americans are looking for natural lipid-balancing approaches that do not carry the risk associated with common cholesterol-lowering drugs. Today we will cover Cholesterol Health and the science behind Bergamot.To help us unpack all the research and studies we have Dr. Stengler joining us today.In addition to authoring 30 books on health and several best-sellers such as “The Natural Physician's Healing Therapies,” “Prescription for Natural Cures,” “Prescription for Drug Alternatives,” and “Outside the Box Cancer Therapies,” Dr. Stengler has been published in several peer-reviewed medical journals such as The International Journal of Family & Community Medicine, Endocrinology & Metabolism International Journal, and Journal of Nutritional Health & Food Engineering.Dr. Stengler's, NMD. the newest book is called, The Holistic Guide to Gut Health.A comprehensive yet accessible approach to healing leaky gut and the many uncomfortable symptoms it causes. Dr Stengler is also the founder of The Stengler Center for Integrative Medicine.Learn more about the products offered at Emerald Labs to help support your Heart Health.Cholesterol Health Bergamot+ Listeners can save 20% OFF when using the cod: Forever at Emeraldlabs.com

Send us a textThe effects of protein restriction on metabolism, liver hormones, brain, and behavior.Episode Summary: Dr. Christopher Morrison talks about how animals sense and prioritize nutrients like protein, discussing defense mechanisms for essentials such as oxygen, water, sodium, and energy; the brain's role in detecting protein deprivation via signals like FGF21; trade-offs between growth, reproduction, and longevity under protein restriction; and reconciling high-protein diets for satiety and muscle maintenance with low-protein benefits for metabolic health and lifespan extension.About the guest: Christopher Morrison, PhD is a professor and researcher at the Pennington Biomedical Research Center in Baton Rouge, Louisiana, where he has worked for over 22 years focusing on nutrition, metabolism, and chronic diseases like obesity and diabetes.Discussion Points:The body prioritizes nutrients hierarchically: oxygen and water first, then sodium, energy, and protein, with weaker defenses for carbs or fats.Animals develop specific appetites for deprived nutrients, like salt or protein, often through post-ingestive learning rather than just taste.Protein restriction (e.g., 5% vs. 20% in diets) increases food intake and energy expenditure in mice to maintain protein levels, even at the cost of extra calories.FGF21, a liver hormone, signals protein deprivation to the brain (via NTS region), driving protein-seeking behavior and metabolic changes; it's essential for low-protein responses.Protein restriction extends lifespan in lab animals by suppressing growth signals like IGF-1 and mTOR, but may impair immunity or wound healing in real-world conditions.High protein aids satiety, weight loss, and muscle building, but overconsumption may shorten lifespan; optimal intake depends on age, activity, and goals (e.g., not for pregnant or elderly).No one-size-fits-all for protein: mild restriction may benefit middle-aged sedentary people for health, while athletes need more; balance avoids excesses.Related content:M&M 106: Diet, Macronutrients, Micronutrients, Taste, Whole vs. Processed Food, Obesity & Weight Loss, Comparative Biology of Feeding Behavior | Stephen Simpson & David Raubenheimer*Not medical advice.Support the showAffiliates: Seed Oil Scout: Find restaurants with seed oil-free options, scan food products to see what they're hiding, with this easy-to-use mobile app. KetoCitra—Ketone body BHB + electrolytes formulated for kidney health. Use code MIND20 for 20% off any subscription (cancel anytime) Lumen device to optimize your metabolism for weight loss or athletic performance. Code MIND for 10% off SiPhox Health—Affordable at-home blood testing. Key health markers, visualized & explained. Code TRIKOMES for a 20% discount. For all the ways you can support my efforts

Darshali Vyas is a pulmonary and critical care fellow at Massachusetts General Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D.A. Vyas, L.G. Eisenstein, and D.S. Jones. The Race-Correction Debates — Progress, Tensions, and Future Directions. N Engl J Med 2025;393:1029-1036.

Send us a textDr. Josh Wageman is a Clinical Lipid Specialist with multiple doctoral degrees who formerly practiced in Endocrinology. His PhD work focused on cholesterol disturbances in Alzheimer's Disease, and although he also has a Doctorate in Physical Therapy, he is best known for his role in teaching lipid physiology.He serves as an adjunct professor at several medical programs and his goal is to help you, whoever you are, NOT have heart attacks, strokes, and dementia by explaining complicated biochemical concepts in a relatable way!Employing a smorgasbord of metaphors, pictures, and catchphrases, his latest book The Home Security System and the Lipid Neighborhood serves as a valuable reference for clinicians and non-clinicians alike, bringing refreshing relatability to complex biochemical topics. Through a lipid-lens, you'll learn, laugh, and love your way through its pages…and in the end, you'll undoubtedly add “life to your years!”Dr. Josh Wageman is active in Youth Ministries at Heritage Bible Church in Boise, Idaho, and resides there with his family. He also enjoys Crossfit, basketball, Ultimate Frisbee, and all sports that don't involve skates.Find Dr. Wageman at-Amazon- The Home Security System and the Lipid Neighborhood IG- @wagemanjoshLK- @Josh WagemanFind Boundless Body at- myboundlessbody.com Book a session with us here!

EP. 229:  Grab The Perimenopause Revolution here: drmariza.com/book. → I'm hanging out with my girl Dr. Mariza Snyder in this episode, and let me tell you, she's an absolute powerhouse. With 17 years of experience supporting midlife women, plus her work as an author and speaker, she's all about empowering women to take control of perimenopause and beyond. We dig into her upcoming book, The Perimenopause Revolution, which is packed with tools to help women navigate hormonal changes with confidence. We cover everything from brain health to metabolic wellness, HRT dosing, and even the value of time alone.  Topics Discussed: → What are the first signs of perimenopause? → How can women prepare for perimenopause? → What lifestyle changes help with hormone balance? → How does insulin resistance affect midlife women? → When should you start HRT or see a doctor for perimenopause? Sponsored By: → Sundays | As a Listener of The Dr Tyna Show, you can Get 40% off your first order of Sundays. Go to sundaysfordogs.com/DRTYNA and use code DRTYNA at checkout. → Liver Love | Go to https://store.drtyna.com/products/liverlove Use code LIVER20 for 20% off → Manukora | Head to manukora.com/DRTYNA to save up to 31% & $25 worth of free gifts in the Starter Kit, which comes with an MGO 850+ Manuka Honey jar. → Timeline | Head to timeline.com/DRTYNA and get 20% off with code DRTYNA  → BIOptimizers | For 15% off go to bioptimizers.com/drtyna and use promo code DRTYNA → LMNT | Get a free 8-count Sample Pack of LMNT's most popular drink mix flavors with any purchase at drinklmnt.com/drtyna. Find your favorite LMNT flavor, or share with a friend. On This Episode We Cover:  → 00:00:00 - Introduction → 00:02:32 - Babies and perimenopause → 00:04:40 - Preparing for perimenopause → 00:07:44 - Brain injury, pregnancy, & perimenopause → 00:14:06 - Flat affect & dysregulation → 00:15:44 - Mid 30s health advice → 00:21:48 - First signs of perimenopause → 00:24:08 - Hormone changes & symptoms → 00:27:27 - Insomnia & stress intolerance → 00:29:52 - Metabolic health → 00:32:29 - Insulin resistance → 00:35:20 - Birth control & SSRIs → 00:39:51 - HRT dosing → 00:45:16 - Endocrinology → 00:49:11 - Migraines & chronic pain → 00:51:37 - Cortisol & oxytocin → 00:54:08 - Lifestyle changes → 00:58:10 - The DUTCH test → 00:59:30 - Regenerative medicine & pain → 01:03:36 - Value of time alone → 01:05:31 - Finding the right doctor → 01:11:50 - Where to find Dr. Mariza Show Links:  → Find A Doc Further Listening:  → EP. 114: Perimenopause: A Guide to Navigating Hormonal Shifts with Dr. Mariza Snyder → EP. 225 | The Truth About SSRIs that Your Doctor Isn't Telling You | Solo → EP. 228 | What Every Woman Should Know About Hormones & Vaginal Health | Dr. Anna Cabeca → Hormones Playlist Check Out Dr. Mariza:  → drmariza.com/book → Instagram

Papillary thyroid cancer is the most common type of thyroid cancer, and yet in rare cases, this cancer may originate in locations other than the thyroid glands. In this episode, host Aaron Lohr talks about causes, prevalence, and treatment for papillary thyroid cancer and the rare phenomenon known as ectopic papillary thyroid cancer with Nikita Dhir, MD, of University of Texas Health Science Center at Houston. Dr. Dhir and colleagues presented research at ENDO 2025 in San Francisco titled, “Where Is the Primary Papillary Thyroid Cancer?” Show notes are available at https://www.endocrine.org/podcast/enp101 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Grazia Aleppo, MD, Kasey J. Coyne, MD, and Jelena Kravarusic, MD, PhD, from the Northwestern Medicine Division of Endocrinology, join the Better Edge podcast. The trio discusses a recent clinical trial they led, published in The New England Journal of Medicine. This trial aimed to evaluate the efficacy and safety of using an automated insulin delivery system for treating patients with Type 2 diabetes, a method already well established for those with Type 1 diabetes.

An update on natural thyroid availability and the FDAA correction on disseminated sarcoidosis and stressI'm a former smoker. Should I be concerned about beta carotene in the Alpha Base multivitamin?A comment from a user of lithium orotate for the last eleven yearsDoes long-term use of Horse Chestnut cause a thiamin deficiency?

NOW it all makes sense - and it's backed by science! ONE little hormone, or the lack of it has changed you. And that my friend - is it. Your lack of sleep, your lack- or seeming lack - of empathy, potential heart trouble - and that general feeling that everyone else can suck a lemon - because you're going to do what you want now. All explained. According to the Harvard article, What is oxytocin? "Oxytocin is a hormone that's produced in the hypothalamus and released into the bloodstream by the pituitary gland. Its main function is to facilitate childbirth, which is one of the reasons it is called the "love drug" or "love hormone." Oxytocin, like endorphins or serotonin, is a type of hormone in your body that promotes positive feelings.” And according to the Journal of Endocrinology, “Oxytocin is a neurohormone that regulates emotionality, social behaviors, and fundamental physiological systems. Localization of oxytocin receptors in the brain, reproductive tissues, bone, and heart support their role in mental health and potentially sleep, along with reproductive and cardiovascular functions.”   Scientific references discussed: https://joe.bioscientifica.com/view/journals/joe/262/1/JOE-23-0396.xml   https://www.health.harvard.edu/mind-and-mood/oxytocin-the-love-hormone Thank you for joining me today! I'm having a blast creating Fabulous Over 50 & it would be an honor to have you share it with someone who would enjoy it. Thank you! Want more? Go to the website and you'll find many ways to live your best life over 50! I'd love to hear what you think about this episode, and what you'd like to hear about in the future. Send me a message HERE. Have a blessed week, Jen Want to connect? You can find me in the following places: JenHardy.net Facebook Instagram LinkedIn  

In this episode, Tina speaks with Carrots ‘N' Cake coach and FDN Practitioner, Jennifer Woodward, about the importance of functional testing for women during their perimenopausal years. Jennifer provides clarity around some of the imbalances that women might experience in perimenopause and some of the common markers we see on functional tests. Jennifer discusses: - Common symptoms in perimenopause - The importance of functional lab testing - How the GI-MAP and DUTCH can provide clues - Minerals as the spark plugs of the body - Intermittent fasting and whether it's helpful or harmful - Cardio as an extra stressor - And more… Connect with Tina Haupert: https://carrotsncake.com/ Facebook: Carrots 'N' Cake https://www.facebook.com/carrotsncake Instagram: carrotsncake https://www.instagram.com/carrotsncake YouTube: Tina Haupert https://www.youtube.com/user/carrotsncake Pinterest: Carrots 'N' Cake Hormone Testing & Nutrition Coaching https://www.pinterest.com/carrotsncake/ About Tina Haupert: Tina Haupert is the owner of Carrots ‘N' Cake as well as a Certified Nutrition Coach and Functional Diagnostic Nutrition Practitioner (FDN-P). Tina and her team use functional testing and a personalized approach to nutrition to help women find balance within their diets while achieving their body composition goals. Connect with Jennifer Woodward: www.jenniferwoodwardnutrition.com Instagram: https://www.instagram.com/the_period_fdn/ Facebook: https://www.facebook.com/jenniferwoodwardnutritionist About our Guest: Jennifer Woodward holds a Master's of Science in Integrative Nutrition and is a certified Functional Diagnostic Nutrition Practitioner and a Board Certified Functional Wellness Coach. She served as executive director of the Association of Functional Diagnostic Nutrition Professionals, growing the association from less than 500 to over 850 members in three years. She is the creator of the acclaimed FDN Business School and she loves getting to help new FDNs thrive professionally. Jennifer was recently a quarter-long guest lecturer in graduate Endocrinology at Parker University and has been an independent contractor for multiple functional medicine practices across the United States. She loves to be active with her high school sweetheart husband and four kids. Don't get her started on weight lifting for women, or pickleball!

Send us a textMulti-Metabolic Week focuses on the idea that MASLD and MASH are elements in a systemic set of Multi-Metabolic issues. This conversation is the second of two looking at the concept of the "Multi-Metabolic Clinic," a clinic that treats the entire spectrum of multi-metabolic diseases.This conversation starts by focusing on how the two clinics train other physicians and practices on multi-metabolic issues. The EDOM clinic in Spain is certified to provide nutritional training to other practices across the country, while the newer, smaller Trajectory Health Partners practice provides support on use of FibroScan and, more recently, Velacur from Sonic Incytes. Louise notes how important training is for optimal use of scanning devices, which includes both technical proficiency and knowledge of how to educate and motivate patients using the results of the scans. From there, the conversations shifts to focus on differences between treating patients in a conventional practice vs. a multi-metabolic one. The key differences involve length of patient visit and use of allied providers to educate patients more fully. Next, Louise asks whether the clinics have data on reducing the number of patients needing to go to a hospital. EDOM has data while the younger Trajectory has a clear sense this happens but no large-scale practice data to support this sense. Louise's last question is to ask how each physician would "sell" colleagues in their specialty on why to set up a multi-metabolic practice. The answers reflect the different specialties in which the physicians were trained originally (endocrinology in Spain, gastroenterology in the U.S.) but have significant common elements. 

Send us a text00:00:00 - Surf's Up: Season 6, Episode 11 This week, we modify our usual episode structure to focus on multi-metabolic practices and constructs. The multi-metabolic practices covered this week are run by non-hepatologists who have chosen to focus on the liver in a broader cardiometabolic context. They include two practices discussed during a two-part roundtable, one run by US gastroenterologist Dr. Karen Jerome-Zapadka and the EDOM practice in Spain, run by endocrinologists. The expert interview is with Dr. Emily Andaya, an internist who helms a cardiometabolic practice in Indiana, US, that focuses on the liver. 00:14:23 - Roundtable Part I: Groundbreaker and introductionThe core of the episodes started during the weekly groundbreakers, as guests began to describe the path that brought them from single-disease specialization to the broader multi-metabolic practice.. Immediately after the groundbreakers, participants describe their clinics today, including patient population and principles underlying their approach to treatment.00:26:15 - Roundtable Part II: Tools they useGuided by Louise, the specialists discuss the devices they use to screen and stage patients and the drugs they use to treat them. One interesting item that emerges is that EDOM relies on a 0-to-4 disease severity classification, but it does not align point-by-point with the 4-point fibrosis scale common in MASH. 00:40:28 - Roundtable Part III: Training Providers in the ClinicsLouise starts this segment by asking the EDOM team how they train practitioners in their clinic. EDOM trains practitioners in nutrition and technologists in the proper use of scanning devices. Karen comments that one big issue in re-training involves the length of visits: 15 minutes for a typical GI visit vs. 60 minutes for an initial multi-metabolic session and 30 minutes for follow-ups. Along with this, the information gathering technique are different.00:50:57 - Roundtable Part IV: Patient Health and Wrap-upLouise asks participants whether and how they have measured the impact the multi-metabolic approach has on patients' health (profound in both cases) and whether they are seeing an increase in HCC. Karen sees a difference among her long-term patients, while EDOM refers patients before their fibrosis reaches cirrhosis stage. In the last part of the episode, panelists share perspectives on how their initial specialties fit with the broader multi-metabolic practice and the kinds of impact they can have on patients.01:12:50 - Expert: Dr. Emily Andaya discusses US initiatives in multi-metabolic healthThis week's expert is Dr. Emily Andaya, an Indiana (US)-based internist whose practice has expanded to take on a multi-metabolic focus. She begins by discussing her recent attendance at the American Society for Preventive Cardiology (SPC) meeting in Boston, where she heard a talk by Dr. Christos Montzoros, an endocrinologist and multi-metabolic advocate, who emphasized the importance of incorporating the liver into preventive cardiology's focus. Louise and Emily agree that cardiometabolic focus involves evaluating general, overall health, but Emily discusses how this might require a deeper or broader testing protocol for each target organ. Emily describes the 4-point CKM scale and Louise asks how fibrosis or NAS scoring, as deployed in the MASH CRN system, might be valuable here. This is a far-ranging conversation, but one special point of interest involves the psychological benefit of telling a patient they need to treat one (multi-metabolic) condition, instead of separate heart, kidney, endocrinological and liver conditions, which might feel far more overwhelming. 01:48:48 - ConclusionBecause Roger is on vacation, there is no business report this week.

After seven years, we have reached our 100th episode! For this, we talk about growth hormone deficiency, about causes, prevalence, why some types may become permanent, available treatments, and the importance of adherence to treatment plans. Host Aaron Lohr talks with Sandro Loche, MD, of Bambino Gesù Children’s Hospital in Rome, Italy. Recently, Dr. Loche and colleagues presented research at ENDO 2025 in San Francisco titled, “Adherence to GH Treatment in the Transition Age: A Prospective Study.” Show notes are available at https://www.endocrine.org/podcast/enp100 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Dr. Sara Yap, Riverside Endocrinologist, joins us to discuss important screenings related to diabetes.

A new alarming report shows Americans on average get more than 50% of their calories from ultra-processed foods. We spoke with Dr. Brian Wojeck, an Assistant Professor at Yale University in the Section of Endocrinology, about the findings and what exactly are ultra-processed foods? Image Credit: Getty Images

08/03/25The Healthy Matters PodcastS04_E21 - The Small, but Mighty ... THYROID!With Special Guest:  Dr. Sreekant Avula, MBBSSometimes, the why behind how we feel is a little hard to pinpoint.  Are you feeling sluggish and tired all the time, even though you're getting enough rest?  Are you gaining or losing weight without even trying?   Well, it could have something to do with your small, but mighty, butterfly-shaped gland in your neck - the thyroid.  Turns out this gland is responsible for quite a bit in the body!But what exactly does it control?  What happens to us when something goes wrong?  And, of course, how do we fix it when something does?  On Episode 21 of our show, we'll be joined by endocrinologist Dr. Sreekant Avula to get the basics on this essential piece of the human puzzle.  We'll go over what makes it tick, what it makes tick, why we need it, and what can be done when something goes wrong with it.  We've all got a thyroid, so there's something here for everyone.  Join us!We're open to your comments or ideas for future shows!Email - healthymatters@hcmed.orgCall - 612-873-TALK (8255)Get a preview of upcoming shows on social media and find out more about our show at www.healthymatters.org.

Trigger warning: this is a direct conversation about human anatomy, infertility, and gender-specific challenges to conceiving biological children. Discussions around fertility and age drive so much of who we select as dating partners, but are we basing those assumptions on facts, or myths? We'll dive in and see if we can help clarify how age should and shouldn't play into your assessment of who you should choose to marry and raise children with. See the bottom of the show notes for citations. Singles at SEA 2026: We'll be setting sail February 6-9, 2026 out of Miami, Florida on Wonder of the Seas and visiting The Bahamas! Prices subject to change, but you only need $200 to book a cabin/$100 per person if you book with a friend. Call Chelsea Fennell at 864-901-8233 Email: spinell@dreamvacations.com Get the From Singles, to Shepherds Info Guide Here! https://the-synchrony-project.mykajabi.com/from-singles-to-shepherds Contact: If you want to join the conversation about this topic and give your thoughts, reach out on Instagram, Facebook, YouTube, or at questions@synchronyproject.com. Learn more about our matchmaking services and dating resources at https://synchronyproject.com. Intro/Outro music by: Balloon Planet, "Write Your Own Story," https://artlist.io/royalty-free-music/song/write-your-own-story/135437 Citations for this episode: Prevalence and factors associated with infertility in reproductive-aged women in China Reproductive Health (2021) https://reproductive-health-journal.biomedcentral.com/articles/10.1186/s12978-021-01298-2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253726/ Semen quality and aging: systematic review and meta-analysis Asian Journal of Andrology (2018) https://www.sciencedirect.com/science/article/pii/S2090598X18300068 Age-related increase in sperm DNA fragmentation: A prospective study Frontiers in Aging (2025) https://www.frontiersin.org/journals/aging/articles/10.3389/fragi.2025.1603916/full Effects of age on semen parameters and ART outcomes: A systematic review Frontiers in Endocrinology (2023) https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2023.1194455/full Semen parameters decline with age in healthy men Human Reproduction (2006) https://academic.oup.com/humrep/article/21/11/2868/2939168 Temporal trends in sperm count: A systematic review and meta-regression analysis Human Reproduction Update (2017) https://academic.oup.com/humupd/article/23/6/646/4035689 Delayed childbearing: More women are having their first child later in life OECD Society at a Glance (2024) https://webfs.oecd.org/els-com/Family_Database/SF_2_3_Age_mothers_childbirth.pdf OECD Society at a Glance 2024 – Fertility Chapter OECD (2024) https://www.oecd.org/en/publications/society-at-a-glance-2024_918d8db3-en/full-report/fertility_748a5055.html Spain has some of the oldest first-time mothers in the world Business Insider (2024) https://www.businessinsider.com/spain-some-oldest-moms-world-babies-born-women-over-40-2024-12 CDC National Health Statistics Reports: Male Fertility in the US (2015–2019) CDC / NCHS https://www.cdc.gov/nchs/data/nhsr/nhsr202.pdf

What does it really mean to live a healthy, full life with type 2 diabetes? Listen to this special interview with Dr. Victoria Bouhairie, a board-certified endocrinologist specializing in Endocrinology, Obesity, and Lifestyle Medicine. She shares expert advice on how to manage blood sugar, protect your heart, and build lasting habits that support your overall health and your numbers. Whether you're newly diagnosed or have been living with diabetes for years, this conversation will leave you informed, empowered, and inspired.This episode is brought to you by ReliOn Community, an amazing program available exclusively for Walmart customers with a ReliOn Premier meter. Get free diabetes tips, recipes and support sent right to your phone– visit ReliOnBGM.com/community to learn more. The medical information in this podcast is provided as an information resource only. It is not in any way intended to be nor should you rely on it as a substitute for professional medical evaluation, diagnosis, advice and treatment.

On this episode of the Huddle, Kelly Postiglione Cook, RN, MSN, ANP-BC, CDCES, BC-ADM, and Sean Oser, MD, MPH, CDCES have a conversation about the importance of utilizing automated insulin delivery systems, like the iLet bionic pancreas, more widely in primary care. They provide insight into a study that evaluated the success of implementing use of the iLet bionic pancreas in a primary care setting, how the results illustrated that this technology can be more widely utilized in these settings, and the role diabetes care and education specialists can play in this work.This episode is sponsored by Beta Bionics. Episode References: Bionic Pancreas Research Group. Multicenter, randomized trial of a bionic pancreas in type 1 diabetes. N Engl J Med 2022;387:1161-1172 DOI: 10.1056/NEJMoa2205225 Russell SJ, Selagamsetty R, Damiano E. Real-world efficacy of the iLet bionic pancreas in adults and children during the first eighteen months of commercial availability. Presented at the American Diabetes Association 85th Scientific Sessions, June 20-23, 2025, Chicago, IL.   Oser SM, Putman MS, Russel SJ, et al. Assessing the iLet Bionic Pancreas deployed in primary care and via telehealth: a randomized clinical trial. Clin Diabetes 2025; cd240104. https://doi.org/10.2337/cd24-0104 Oser C, Parascando JA, Kostiuk M, et al. Experiences of people with type 1 diabetes using the iLet bionic pancreas in primary care: A qualitative analysis. Clin Diabetes 2024 https://doi.org/10.2337/cd24-0060.  Sulik B, Postiglione Cook K, MacLeod J. Meals no longer need to be math problems: Shifting from precise carbohydrate counting to a continuum of carbohydrate awareness as automated insulin delivery advances. Diabetes Technology and Obesity Medicine 2025;1(1):79-83. DOI: 10.1089/dtom.2025.0010.  Resources:Learn more about Beta Bionics here: https://www.betabionics.com/Explore the latest in diabetes technology on danatech: danatech l Diabetes Technology Education for Healthcare ProfessionalsLearn more about a two-part course on integrating diabetes technology into primary care, put on through the collaboration of AANP and ADCES:Part 1: Integrating Diabetes Technology into Primary Care Part 1: Overview and Clinical ScenariosPart 2: Integrating Diabetes Technology into Primary Care Part 2: Interactive Case StudiesDive deeper into how diabetes technology can be incorporated into primary care on another recent episode of The Huddle featuring Kathryn Evans Kreider DNP, FNP-BC, BC-ADM, FAANP: https://thehuddle.simplecast.com/episodes/embracing-diabetes-technology-in-primary-care Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join.

A breakthrough in inflammatory support has arrived in the natural health market. PEA, which stands for palmitoylethanolamide, is a naturally occurring fatty acid derivative made in the body and found in small amounts in foods. Several human studies have demonstrated that PEA has broad- spectrum pain-relieving properties, anti-inflammatory effects, and nerve protection.To help us unpack all the research and studies we have Dr. Stengler joining us today.In addition to authoring 30 books on health and several best-sellers such as “The Natural Physician's Healing Therapies,” “Prescription for Natural Cures,” “Prescription for Drug Alternatives,” and “Outside the Box Cancer Therapies,” Dr. Stengler has been published in several peer-reviewed medical journals such as The International Journal of Family & Community Medicine, Endocrinology & Metabolism International Journal, and Journal of Nutritional Health & Food Engineering.Dr. Stengler's, NMD. The newest book is called, The Holistic Guide to Gut Health. A comprehensive yet accessible approach to healing leaky gut and the many uncomfortable symptoms it causes. Dr Stengler is also the founder of The Stengler Center for Integrative Medicine.Talking Points:Palmitoylethanolamide (PEA), is a naturally occurring fatty acid derivative made in the body and found in small amounts in foods. PEA was first discovered in 1957 by scientists at Merck Sharp & Dohme, who isolated it from egg yolk, peanut meal, and soy lecithin. They found that PEA had anti-inflammatory properties in guinea pigs.However, PEA's role as a potential therapeutic agent was not widely recognized until 1993, when Rita Levi-Montalcini and her colleagues published research that suggested PEA has anti-inflammatory properties. Levi-Montalcini's group termed PEA an autocoid local injury antagonist (ALIA), and suggested that it acts locally to counteract injury.Multiple studies have demonstrated that PEA improves all sorts of pain. For example, a 2023 analysis of 11 studies found that PEA improved pain of various conditions, including muscle and joints, nerves, gynecological, and digestive. In terms of joint pain, a high-quality study demonstrated that PEA significantly reduced adult joint pain compared to placebo. Moreover, 8 clinical trials demonstrated that PEA was effective for low back pain, sciatica, and carpal tunnel syndrome. Even migraine headache pain was shown in published research to be improved with PEA.Lipid mediators help to balance the immune, nervous, and endocrine systems, affecting pain pathways related to inflammation. But unfortunately, due to changing diets, many of us do not get the nutrition and activity we need to make enough PEA ourselves.Supplemental PEA, by Levagen+ is properly formulated for optimal bioavailability, 75% more bioavailable to cell receptors than dietary forms. Levagen+ liposomal delivery of PEA has been clinically studied and shows benefits in joint pain, nerve pain, migraine, infections, sleep, and cognitive function.Learn more about Dr. Mark Stengler, NMDLearn more about Emerald Labs PEA+ Levagen Use the code: Forever and get 20% off your order.

If you're constantly feeling tired, gaining weight, struggling with anxiety, or just feeling "off," your thyroid could be the reason. In this podcast episode of Baptist HealthTalk, Endocrinologist Dr. Angel Alejandro breaks down common symptoms of thyroid disorders, when and how to get tested, and clears up some of the biggest myths around supplements, diet, and treatment options. You'll also learn why thyroid conditions are more common in women, how to spot early warning signs, and what questions to ask your doctor.Watch now to learn how to better understand your thyroid and take control of your health.Host:Sandra Peebles Emmy Award-Winning JournalistGuestDr. Angel Alejandro, M.D.Endocrinologist

We're diving into a topic that's generating a lot of buzz in the T1D community: GLP-1s. To break down what these medications actually do, what the research says, and how they might benefit people with type 1 diabetes, we're joined by pediatric endocrinologist Dr. Justin Gregory. We explore what GLP-1s are, how they work in the body, and why they're attracting so much attention in T1D care. Dr. Gregory shares insights on their effects on blood sugar, insulin needs, and insulin sensitivity (and whether those benefits are purely tied to weight loss or something more direct). Whether you've only seen GLP-1s mentioned on social media or you've already started a conversation with your healthcare team, this episode brings clarity to the hype and the hope. Don't miss this conversation - we're answering all the questions the T1D community has been waiting for.Quick Takeaways:Everything you need to know about GLP-1s: What they are, who they are meant for & why they are getting so much hypeThe impact these medications have on T1D: Blood sugar, insulin needs, insulin sensitivity, and more Breaking down the risks: Direct impact on T1D (blood sugars, insulin needs, etc.) and side effects of long-term use How GLP-1s are being prescribed off-label to type 1s and the important conversations people with T1D should have with their provider before starting them Timestamps:[03:13] Dr. Gregory's journey into Endocrinology [03:37] “Diagnosed with T1D and I was told, your Air Force career is over…”[05:21] “My research says, what is the cost of putting too much insulin in the wrong place?”[09:43] One of the most underappreciated aspects of T1D: Insulin sensitivity  [XX:XX] “Insulin sensitivity is 30 to 50% lower in type 1 diabetes compared to mass control.”[12:34] How to determine your insulin sensitivity (and increase it)[21:13] The breakdown of GLP-1s [23:25] Understanding GLP-1s efficacy in T1D [27:09] Who will benefit from these medications vs. who might hurt [30:41] Insulin resistance with a healthy BMI: How is it possible?[34:42] Prescribing these medications to children [38:34] How GLP-1s could be used for the newly diagnosed T1D population[39:00] Dr. Gregory's expectations for the future and evolution of these medications [41:06] Pregnancy + GLP-1s[46:24] “When you come off of it, if you're not staying on it forever, what happens?”What to do now: Follow me @lauren_bongiorno and @riselyhealth on Instagram to stay in the loop when new episodes drop.Apply for coaching and talk to our team so you can reclaim the life you deserve.  Join the PEP (Parents Empowering Parents) Squad, a Facebook group created by the Diabetes Research Institute. This is a place where caregivers of kids with T1D can share stories, ask questions, and learn more about how to get involved with research, advocacy, and fundraising through DRI. 

Send us a textThe pursuit of optimal health as we age requires more than just conventional medicine—it demands a deeper understanding of how our hormones, genetics, and metabolism interact. In this continuation of the conversation with Dr. Elena Christofides, Host Dr. Holly Thacker goes beyond the surface of women's health concerns to explore groundbreaking approaches that can literally change how we age.Dr. Christofides reveals why comprehensive blood testing should include genetic markers that most physicians overlook. From MTHFR mutations affecting B vitamin metabolism to hemochromatosis genes common in those with Northern European ancestry, these hidden factors can dramatically impact metabolic health. Her revolutionary approach includes growth hormone screening for everyone—not just elite athletes—because deficiencies following head trauma (including domestic violence) affect one in five people and accelerate aging processes.Throughout the conversation, Dr. Christofides and Dr. Thacker emphasize that what many dismiss as "normal aging" is often addressable with personalized medical approaches.For anyone frustrated by unexplained weight gain, fatigue, poor sleep quality, or declining physical performance despite "normal" lab work, this episode offers hope and actionable insights.To learn more about Dr. Elena Christofides, visit endocrinology-associates.com.Fit, Healthy & Happy Podcast Welcome to the Fit, Healthy and Happy Podcast hosted by Josh and Kyle from Colossus...Listen on: Apple Podcasts SpotifySupport the show

In this episode of the Diabetes Innovators Series, Rob interviews Dr. Viral N Shah discussing the Adjust T1D trial, which investigates the effects of semaglutide, a GLP-1 agonist, on adults with type 1 diabetes. The trial aims to explore adjunctive treatment options beyond insulin, focusing on improving glycemic control, weight loss, and overall patient outcomes. Dr. Shah shares insights on the trial's design, results, safety profile, and implications for future diabetes management, emphasizing the need for continued research and community support. Chapters 00:00 Introduction to the Adjust T1D Trial 03:06 Understanding Type 1 Diabetes and Treatment Options 05:46 Results of the Adjust T1D Trial 08:54 Safety and Efficacy of Semaglutide 11:45 Implications for Type 1 Diabetes Management 14:52 Future Research and Community Impact Resources: Dr. Viral Shah